As of 2024-12-13, the EV/EBITDA ratio of Abbvie Inc (ABBV) is 13.82. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Abbvie's latest enterprise value is 369,872.97 mil USD. Abbvie's TTM EBITDA according to its financial statements is 26,761.00 mil USD. Dividing these 2 quantities gives us the above Abbvie EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 17.5x | 15.6x |
| Forward P/E multiples | 22.9x - 37.1x | 30.8x |
| Fair Price | 94.04 - 228.29 | 170.20 |
| Upside | -45.7% - 31.8% | -1.7% |
| Date | EV/EBITDA |
| 2024-12-12 | 13.82 |
| 2024-12-11 | 13.90 |
| 2024-12-10 | 13.99 |
| 2024-12-09 | 14.04 |
| 2024-12-06 | 14.02 |
| 2024-12-05 | 14.02 |
| 2024-12-04 | 14.04 |
| 2024-12-03 | 14.37 |
| 2024-12-02 | 14.39 |
| 2024-11-29 | 14.46 |
| 2024-11-27 | 14.47 |
| 2024-11-26 | 14.35 |
| 2024-11-25 | 14.08 |
| 2024-11-22 | 14.07 |
| 2024-11-21 | 13.72 |
| 2024-11-20 | 13.46 |
| 2024-11-19 | 13.38 |
| 2024-11-18 | 13.37 |
| 2024-11-15 | 13.28 |
| 2024-11-14 | 13.59 |
| 2024-11-13 | 13.63 |
| 2024-11-12 | 13.68 |
| 2024-11-11 | 13.90 |
| 2024-11-08 | 15.56 |
| 2024-11-07 | 15.63 |
| 2024-11-06 | 15.67 |
| 2024-11-05 | 15.70 |
| 2024-11-04 | 15.62 |
| 2024-11-01 | 15.83 |
| 2024-10-31 | 15.85 |
| 2024-10-30 | 15.69 |
| 2024-10-29 | 14.90 |
| 2024-10-28 | 14.91 |
| 2024-10-25 | 14.79 |
| 2024-10-24 | 14.91 |
| 2024-10-23 | 14.79 |
| 2024-10-22 | 14.85 |
| 2024-10-21 | 14.70 |
| 2024-10-18 | 14.86 |
| 2024-10-17 | 14.84 |
| 2024-10-16 | 14.96 |
| 2024-10-15 | 15.05 |
| 2024-10-14 | 15.30 |
| 2024-10-11 | 15.21 |
| 2024-10-10 | 15.22 |
| 2024-10-09 | 15.25 |
| 2024-10-08 | 15.13 |
| 2024-10-07 | 15.17 |
| 2024-10-04 | 15.21 |
| 2024-10-03 | 15.29 |